EPIT.TA

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

DCF fair valuemodel estimate

Intrinsic value

$98.93

Price

$387.10

Implied downside

-74%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
EPIT.TAEpitomee Medical Ltd	$401.50	+9.34%	$121M	—
BONS.TABonus BioGroup Ltd.	$17.70	+2.31%	$207M	—
BVC.TABATM Advanced Communications Ltd.	$47.30	+0.85%	$161M	—
DNA.TADna Group (T.R.) Ltd	$110.90	+0.00%	$137M	—
GEFR.TAGeffen Residence & Renewal Ltd	$78.00	+0.65%	$321M	—
GFC-M.TAG.F.C Green Fields Capital Ltd.	$1603.00	-0.06%	$161M	—
GOHO.TAGolden House Ltd	$1092.00	+1.49%	$169M	—

Source: Financial Modeling Prep · peers by sector/industry

Epitomee Medical Ltd

Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.

www.epitomeemedical.com

Employees: 44
IPO / List date: Dec 15, 2021
HQ: IL

Held by traders on TradeandTell

No one on the platform currently holds EPIT.TA.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in EPIT.TA as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded EPIT.TA yet.